Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 21 Jul 2026 How Scientists Can Revive Global Health Drug Development Think Global Health
In the media 15 Jul 2026 Dengue outbreak complicates Bangladesh measles crisis response The Telegraph
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Scientific articles 22 Apr 2024 Representations of Chagas disease among Bolivian immigrants in the city of São Paulo Frontiers in Tropical Diseases
Scientific articles 19 Apr 2024 Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model PLOS Neglected Tropical Diseases
Scientific articles 16 Apr 2024 Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform PLOS Neglected Tropical Diseases
Scientific articles 2 Apr 2024 AI is a viable alternative to high throughput screening: a 318-target study Nature Scientific Reports
Scientific articles 29 Mar 2024 Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148 Organic Process Research & Development
Scientific articles 26 Mar 2024 High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae eBioMedicine
Scientific articles 26 Mar 2024 Towards enhanced control of mycetoma: a roadmap to achieve the UN’s sustainable development goals by 2030 Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles 15 Mar 2024 Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers Clinical and Translational Science
Scientific articles 21 Feb 2024 Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development PLOS Neglected Tropical Diseases
Scientific articles 20 Feb 2024 A sample-centric and knowledge-driven computational framework for natural products drug discovery ACS Central Science
Scientific articles 31 Jan 2024 Onchocerciasis drug discovery: In vitro evaluation of FDA-approved drugs against onchocerca gutturosa in Gambia Pharmaceutics
Scientific articles 30 Jan 2024 Late-stage diversification of pyrazoles as antileishmanial agents ChemMedChem
Scientific articles 24 Jan 2024 Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains Antiviral Research
Scientific articles 23 Jan 2024 Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens iScience
Scientific articles 21 Jan 2024 Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa Clinical Pharmacology and Therapeutics
Scientific articles 10 Jan 2024 Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial The Lancet Infectious Diseases
